From schools of fish darting away from sharks to flocks of starlings swirling through the sky, the animal kingdom is full of ...

A new nanozyme-antibody platform selectively targets HER2-positive tumors, disrupting gene expression and reducing metastasis ...

Research Highlight Published: August 2010 Genetics Gene-expression profiling in leukemia—a valuable diagnostic tool Lisa Richards Nature Reviews Clinical Oncology 7, 422 (2010) Cite this article ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Researchers have removed mitochondria from cells to better study their functions in regulating cell death, differentiation ...

We’re in the midst of a paradigm shift in biomarker science. | The right biomarker signature can de-risk trials, guide ...

By using a genetic technique developed at UT Southwestern Medical Center that forces cells to rid themselves of mitochondria, ...

Investigators compared risk prediction using PathomIQ's platform to molecular test results, evaluating its ability to predict biochemical recurrence in high-risk patients.

The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...